New 172-page Whistleblower Complaint to SEBl Documents Sun Pharma’s Nexus with Aditya Medisales – I
The Securities and Exchange Board of India (SEBI) has received a new complaint, a few weeks ago, against Sun Pharma. This too has been filed by the same whistleblower who had filed a complaint in September last year, which was first reported by Moneylife.
 
Archived Premium Content
This article is outside your subscription period. You can buy this article individually.
SINGLE ARTICLE
Rs 50-Rs 100 + GST
Access will be given ONLY to this article.
 
Already a subscriber ? Log in
Free Helpline
Legal Credit
Feedback